AUROBINDO PHARMA FDA Approval ANDA 216557

ANDA 216557

AUROBINDO PHARMA

FDA Drug Application

Application #216557

Application Sponsors

ANDA 216557AUROBINDO PHARMA

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET, EXTENDED RELEASE;ORAL30MG0ISOSORBIDE MONONITRATEISOSORBIDE MONONITRATE
002TABLET, EXTENDED RELEASE;ORAL60MG0ISOSORBIDE MONONITRATEISOSORBIDE MONONITRATE
003TABLET, EXTENDED RELEASE;ORAL120MG0ISOSORBIDE MONONITRATEISOSORBIDE MONONITRATE

FDA Submissions

UNKNOWN; ORIG1AP2022-11-07STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

AUROBINDO PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216557
            [companyName] => AUROBINDO PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"30MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"60MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"120MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/07\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.